Live feed16:05:00·11dPRReleasevia QuantisnowSpruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS SymposiumByQuantisnow·Wall Street's wire, on your screen.SPRB· Spruce Biosciences Inc.Health Care
